Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: An analysis of microbiological data

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 5, 2008, Pages 414-419

  Samonis, George ^a   Kofteridis, Diamantis P ^a   Saloustros, Emmanouil ^a   Giannopoulou, Konstantina P ^b   Ntziora, Fotinie ^b   Christidou, Athanasia ^a   Maraki, Sofia ^a   Falagas, Matthew E ^b,c  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FUNGUS ISOLATION; GENERAL HOSPITAL; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGEMIA; GREECE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 42449133385     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701765657     Document Type: Article

References (23)

1. Falagas, ME, Apostolou, KE and Pappas, VD. (2006) Attributable mortality of candidaemia: A systematic review of matched cohort and case control studies. Eur J Clin Microbiol Infect Dis, 25, pp. 419-425.
2. Bedini, A., Venturelli, C., Mussini, C., Guaraldi, G., Godeluppi, M. and Borghi, V. (2006) Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin Microbiol Infect, 12, pp. 75-80.
3. Pasqualotto, AC, Nedel, WL, Machado, TS and Severo, LC. (2005) A 9-y study comparing risk factors and the outcome of paediatric patients and adults with nosocomial candidaemia. Mycopathologia, 160, pp. 111-116.
4. Tortorano, AM, Peman, J. and Bernhardt, H. (2004) Epidemiology of candidaemia in Europe: Results of a 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis, 23, pp. 317-322.
5. Verma, AK, Prasad, KN, Singh, M., Dixit, AK and Ayyagari, A. (2003) Candidaemia in patients of a tertiary health care hospital from north India. Indian J Med Res, 117, pp. 122-128.
6. Vigouroux, S., Morin, O., Moreau, P., Harousseau, JL and Miplied, N. (2006) Candidaemia in patients with haematological malignancies: analysis of 7 y experience in a single centre. Haematologica, 91, pp. 717-718.
7. Chryssanthou, E. (2001) Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method. J Clin Microbiol, 39, pp. 4181-4183.
8. Cuenca-Estrella, M., Rodriguez, D. and Almirante, B. (2005) Barcelona Candidaemia Project Study Group: In vitro susceptibilities of bloodstream isolates of Candida species to 6 antifungal agents. Results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother, 55, pp. 194-199.
9. Diekema, DJ, Messer, SA, Brueggemann, AB, Coffman, SL, Doern, GV, Herwaldt, LA and Pfaller, MA. (2002) Epidemiology of candidaemia: 3-y results from the Emerging Infections and the Epidemiology of Iowa Organisms Study. J Clin Microbiol, 40, pp. 1298-1302.
10. Ostrosky-Zeichner, L., Rex, JH and Pappas, PG (2003) Antifungal susceptibility survey of 2000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother, 47, pp. 3149-3154.
11. Takakura, S., Fujihara, N., Saito, T., Kudo, T., Iinuma, Y. and Ichiyama, S. (2004) National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to 6 antifungal agents including voriconazole and micafungin. J Antimicrob Chemother, 53, pp. 283-289.
12. Rex, JH, Pfaller, MA and Walsh, TJ (2001) Antifungal susceptibility testing: Practical aspects and current challenges. Clin Microbiol Rev, 14, pp. 643-658.
13. Viudes, A., Peman, J., Canton, E., Ubeda, P., Lopez-Ribot, JL and Gobernado, M. (2002) Candidaemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis, 21, pp. 767-774.
14. Antunes, AG, Pasqualotto, AC, Diaz, MC, d'Azevedo, PA and Severo, LC. (2004) Candidaemia in a Brazilian tertiary care hospital: Species distribution and antifungal susceptibility patterns. Rev Inst Med Trop Sao Paulo, 46, pp. 239-241.
15. Capoor, MR, Nair, D., Deb, M., Verma, PK, Srivastava, L. and Aggarwal, P. (2005) Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis, 58, pp. 344-348.
16. Ellis, M., Hedstrom, U., Jumaa, P. and Bener, A. (2003) Epidemiology, presentation, management and outcome of candidaemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001. Med Mycol, 41, pp. 521-528.
17. Foongladda, S., Sakulmaiwatana, P., Petlum, P. and Vanprapar, N. (2004) Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002. J Med Assoc Thai, 87, pp. 92-99.
18. Pasqualotto, AC, Nedel, WL, Machado, TS and Severo, LC. (2005) A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia. J Hosp Infect, 60, pp. 129-134.
19. Bodey, GP, Mardani, M., Hanna, HA, Boktour, M., Abbas, J. and Girgawy, E. (2002) The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med, 112, pp. 380-385.
20. Guinea, J., Sanchez-Somolinos, M., Cuevas, O., Pelaez, T. and Bouza, E. (2006) Fluconazole resistance mechanisms in Candida krusei: The contribution of efflux-pumps. This study was partially presented at the 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, Czech Republic, May 2004 (Abstract P-1472). Med Mycol, 44, pp. 575-578.
21. Vermitsky, JP, Earhart, KD, Smith, WL, Homayouni, R., Edlind, TD and Rogers, PD. (2006) Pdr1 regulates multidrug resistance in Candida glabrata: Gene disruption and genome-wide expression studies. Mol Microbiol, 61, pp. 704-722.
22. Weems Jr., JJ (1992) Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis, 14, pp. 756-766.
23. Vardakas, KZ, Samonis, G., Michalopoulos, A., Soteriades, ES and Falagas, ME. (2006) Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials. Crit Care Med, 34, pp. 1216-1224.